SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes. Griffin TP, Dinneen SF. Ann Intern Med 2020;173:JC40.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Griffin TP, Dinneen SF. SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes. Ann Intern Med 2020;173:JC40.
PMID: 33075260